×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
APVO – aptevo therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
APVO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/12
12:50 pm
apvo
Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds
High
Report
Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds
12/12
09:25 am
apvo
100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial [Yahoo! Finance]
High
Report
100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial [Yahoo! Finance]
12/12
09:00 am
apvo
100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial
High
Report
100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial
12/9
02:02 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/1
03:05 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/29
09:55 am
apvo
Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan
High
Report
Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan
11/26
08:48 am
apvo
Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation [Yahoo! Finance]
Low
Report
Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation [Yahoo! Finance]
11/26
08:35 am
apvo
Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation
Medium
Report
Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/20
04:31 pm
apvo
Form S-3 Aptevo Therapeutics Inc.
Medium
Report
Form S-3 Aptevo Therapeutics Inc.
12/12
09:06 am
apvo
Form 8-K Aptevo Therapeutics Inc. For: Dec 12
High
Report
Form 8-K Aptevo Therapeutics Inc. For: Dec 12
11/26
08:45 am
apvo
Form 8-K Aptevo Therapeutics Inc. For: Nov 26
Medium
Report
Form 8-K Aptevo Therapeutics Inc. For: Nov 26
11/22
08:46 am
apvo
Form 8-K Aptevo Therapeutics Inc. For: Nov 22
Medium
Report
Form 8-K Aptevo Therapeutics Inc. For: Nov 22
11/20
08:45 am
apvo
Form 8-K Aptevo Therapeutics Inc. For: Nov 20
Low
Report
Form 8-K Aptevo Therapeutics Inc. For: Nov 20
11/14
03:46 pm
apvo
Form SC 13G/A Aptevo Therapeutics Inc. Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G/A Aptevo Therapeutics Inc. Filed by: ARMISTICE CAPITAL, LLC
11/8
02:58 pm
apvo
Form SC 13G Aptevo Therapeutics Inc. Filed by: Hudson Bay Capital Management LP
Low
Report
Form SC 13G Aptevo Therapeutics Inc. Filed by: Hudson Bay Capital Management LP
11/7
08:33 am
apvo
Form 10-Q Aptevo Therapeutics Inc. For: Sep 30
High
Report
Form 10-Q Aptevo Therapeutics Inc. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/10
Aptevo Therapeutics Inc (NASDAQ: APVO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.
20.5%
3/16 Aptevo Therapeutics Provides Update On Ongoing APVO436 Phase 1 Clinical Trial 19.1%
4/13 Form 8-K Aptevo Therapeutics Inc. For: Apr 13 15.2%
10/3 Form 8-K Aptevo Therapeutics Inc. For: Oct 03 11.6%
3/18 Aptevo Therapeutics Inc (NASDAQ: APVO) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 11.2%
11/4 Form 8-K Aptevo Therapeutics Inc. For: Nov 01 8.8%
2/28 Aptevo Therapeutics Sells IXINITY Hemophilia B Therapy for Estimated Proceeds in Excess of $100 Million 7.5%
11/8 Aptevo Therapeutics and Alligator Bioscience Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer 2019 Annual Meeting 7.4%
4/23 Aptevo Therapeutics Inc (NASDAQ: APVO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.7%
8/19 Form 4 Aptevo Therapeutics Inc. For: Aug 16 Filed by: Maddux Randy Joe 5.6%
3/16 Aptevo Therapeutics Provides Update On Ongoing APVO436 Phase 1 Clinical Trial 19.1%
4/13 Form 8-K Aptevo Therapeutics Inc. For: Apr 13 15.2%
10/3 Form 8-K Aptevo Therapeutics Inc. For: Oct 03 11.6%
3/18 Aptevo Therapeutics Inc (NASDAQ: APVO) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 11.2%
11/4 Form 8-K Aptevo Therapeutics Inc. For: Nov 01 8.8%
2/28 Aptevo Therapeutics Sells IXINITY Hemophilia B Therapy for Estimated Proceeds in Excess of $100 Million 7.5%
11/8 Aptevo Therapeutics and Alligator Bioscience Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer 2019 Annual Meeting 7.4%
4/23 Aptevo Therapeutics Inc (NASDAQ: APVO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.7%
8/19 Form 4 Aptevo Therapeutics Inc. For: Aug 16 Filed by: Maddux Randy Joe 5.6%
TOP News Decliners
2/13
Form SC 13G/A Aptevo Therapeutics Inc. Filed by: RENAISSANCE TECHNOLOGIES LLC
-20.0%
3/13 Form 8-K Aptevo Therapeutics Inc. For: Mar 11 -14.5%
8/12 Form 424B5 Aptevo Therapeutics Inc. -13.5%
3/2 Form 8-K Aptevo Therapeutics Inc. For: Feb 28 -12.3%
1/31 Form PRE 14A Aptevo Therapeutics Inc. For: Mar 11 -12.0%
8/9 Q2/2019 6/30/2019 EPS -0.300 ZacksConsensus -0.380 ActVsEst 0.080 - Beat -11.2%
3/5 Aptevo Therapeutics Inc (NASDAQ: APVO) had its "buy" rating re-affirmed by analysts at Roth Capital. -7.0%
10/16 Form 8-K Aptevo Therapeutics Inc. For: Oct 11 -6.9%
3/25 Aptevo Therapeutics Reports 2019 Financial Results and Provides Business Update -6.9%
7/25 Aptevo Therapeutics Reports Continued Progress In APVO210 and APVO436 Clinical Trials -6.4%
3/13 Form 8-K Aptevo Therapeutics Inc. For: Mar 11 -14.5%
8/12 Form 424B5 Aptevo Therapeutics Inc. -13.5%
3/2 Form 8-K Aptevo Therapeutics Inc. For: Feb 28 -12.3%
1/31 Form PRE 14A Aptevo Therapeutics Inc. For: Mar 11 -12.0%
8/9 Q2/2019 6/30/2019 EPS -0.300 ZacksConsensus -0.380 ActVsEst 0.080 - Beat -11.2%
3/5 Aptevo Therapeutics Inc (NASDAQ: APVO) had its "buy" rating re-affirmed by analysts at Roth Capital. -7.0%
10/16 Form 8-K Aptevo Therapeutics Inc. For: Oct 11 -6.9%
3/25 Aptevo Therapeutics Reports 2019 Financial Results and Provides Business Update -6.9%
7/25 Aptevo Therapeutics Reports Continued Progress In APVO210 and APVO436 Clinical Trials -6.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: